ホーム › 濾胞性リンパ腫 › カリフォルニア州

カリフォルニア州における濾胞性リンパ腫の臨床試験

カリフォルニア州内の拠点で、濾胞性リンパ腫に関する36件の研究が参加者を募集しています。

カリフォルニア州内の都市

公式研究テキスト（英語）

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
City of Hope Comprehensive Cancer Center, Duarte
Kaiser Permanente Dublin, Dublin
他21件

被験者募集中第3相

12歳以上 · 全性別 · 2026/10/02更新 · NCT07215910

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

Community Health Project Los Angeles (CHPLA), Los Angeles

被験者募集中健康なボランティア歓迎

18歳以上 · 全性別 · 2026/10/01更新 · NCT07631598

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Research Site, La Jolla

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/30更新 · NCT06542250

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

University of California San Diego (Ucsd) Moores Cancer Center, La Jolla
Stanford Medicine, Palo Alto
UCLA Santa Monica Cancer Care, Santa Monica

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/28更新 · NCT05006716

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

City of Hope - Duarte Cancer Center ( Site 1301), Duarte

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT07634471

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

City of Hope, Duarte
University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07226843

Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma

City of Hope Medical Center, Duarte
City of Hope Orange County Lennar Foundation Cancer Center, Irvine

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/22更新 · NCT06453044

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

City of Hope, Duarte

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07101328

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Research Site, Clovis
Research Site, Los Alamitos
Research Site, San Diego
他1件

被験者募集中第3相

18歳〜130歳 · 全性別 · 2026/09/21更新 · NCT06549595

NEO100 and High-Grade Meningioma

University of Southern California, Los Angeles
Sutter Health Research Institute, San Francisco
Saint John Cancer Institute, Santa Monica

被験者募集中第2相

12歳以上 · 全性別 · 2026/09/15更新 · NCT05023018

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Research Site, Duarte

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/11更新 · NCT06526793

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

David Geffen School of Medicine at UCLA, Los Angeles

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/11更新 · NCT06091254

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

City of Hope Comprehensive Cancer Center, Duarte
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC San Diego Moores Cancer Center, La Jolla
他2件

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/02更新 · NCT06860594